Table 1.
Study population | Study size | Testing | Main diagnoses | Comment and limitations | |
---|---|---|---|---|---|
D’Acremont, Tanzania, 2006 (7) | Paediatric Outpatient District Hospital HIV prevalence: not stated |
1005 | Blood culture, respiratory virus and arboviral nucleic acid amplification testing (NAAT); arboviral serology; Leptospira, Coxiella, and Toxoplasma serology | Viral aetiology in 78% of systemic infections, 100% of nasopharyngeal infections, and 51% of lower respiratory infections Overall: 9% malaria, 4.2% bacteraemia | Challenging to determine causation due to high prevalence (76.9%) of co-infection and lack of healthy controls. |
Crump, Tanzania, 2007–08 (6) | Paediatric/ adult Referral hospitals Inpatient HIV prevalence <13 years 12.2% ≥13 years : 39.0% |
870 | Antigen detection for Cryptococcus, Histoplasma capsulatum, Legionella pneumophila, Streptococcus pneumoniae; blood culture (aerobic and mycobacterial); NAAT for arboviruses; serology for Brucella, Leptospira, Coxiella, and Rickettsia; thick and thin blood film for parasites | <13 years: chikungunya 10.2%, leptospirosis 7.7%, 7.4% spotted fever group rickettsiosis (SFGR), 3.4% bacteraemia, 2.6% Q fever, 2.0% brucellosis, 1.3% malaria, 0.9% fungaemia, ≥13 years: 17.1% bacteraemia, 10.1% leptospirosis, 8.7% SFGR, 7.9% Q fever, 5.3% brucellosis, 5.7% chikungunya, 5.2% fungaemia, 3.5% mycobacteraemia, 2% malaria | Large proportion of patients (64.0% aged <13 years, and 33.2% ≥ 13 years without a aetiologic diagnosis. Respiratory viruses not sought. |
Baba, Nigeria, 2006 (9) | Adult Referral hospital Hospitalisation and HIV status not reported |
310 | Serology for chikungunya, dengue, typhoid, West Nile virus (WNV), yellow fever; thick and thin film for malaria | 67% dengue, 50.2% chikungunya, 32.6% typhoid, 29.4% malaria, 24.9% WNV, | The high prevalence of co-infection of mlalaria, serologically diagnosed typhoid, and arboviral infections highlights challenges of making diagnoses through non-reference standard tests |
Jacob, Uganda, 2008-09 (10) | Adult Referral hospital Inpatients with severe sepsis HIV prevalence 100% |
368 | Antigen detection of Cryptococcus, blood culture (aerobic and mycobacterial); serology for HIV; thick and thin blood film for malaria, | 23.4% Mycobacterium tuberculosis, 11% bacteraemia, 4% non-tuberculous mycobacteria, 2% Cryptococcus neoformans | Highly selected population, with limmited breadth of pathogens investigated |
Chipwaza, Tanzania 2013 (8, 11) | District hospital Outpatient/ Inpatient HIV prevalence not stated | 370 | NAAT for influenza and dengue; serology for brucellosis, chikungunya, dengue, leptospirosis, typhoid; thick and thin blood films for malaria; urine microscopy for bacteria | <5 years: 31.3% dengue, 22.9% malaria, leptospirosis 19.5%, brucellosis 13.2%, typhoid 6.8%, 5.4% chikungunya, 1% influenza ≥5 years: 81.1% dengue, 49.7% brucellosis, 31% leptospirosis, 22.6% malaria, typhoid 14.4%, 4.1 influenza |
High prevalence of co-infection of serologically diagnosed typhoid and zoonotic infections highlights the challenges o determining causation when non-reference standard tests are used |
O’Meara, Maine Kenya, 2011-12 (12, 13) | Paediatric District hospital Outpatient HIV prevalence 0.4% |
370 | Antigen detection for group A Streptococcus, NAAT for adenovirus, influenza A and B, human metapneumovirus, parainfluenza virus 1-3, malaria, respiratory syncitial virus (RSV); serology for Rickettsia, Coxiella; thick and think films for parasites | 22.4% SFGR, ‘ 20.3% influenza A/B, 10.5% adenovirus, 10.1% parainfluenza virus 1-3, 8.9% Q fever, 5.3% RSV 5.2% malaria 5.2%, 3.6% scrub typhus, hMNV 3.2%, group A Streptococcus 2.3%, 1.0% typhus group Rickettsia | Study notable for inclusion of healthy controls, in whom ≥1 pathgen was detected in 49.1%. Limitations include a limited selection of pathogens sought. |